Double Cord Versus Haploidentical (BMT CTN 1101)

Key facts

Sponsor

Medical College of Wisconsin

Principal Investigator

Mary Horowitz, MD, MS, M.D

Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin

Intervention

Haploidentical Bone Marrow Transplant(biological)

Enrollment

368 enrolled

Eligibility

18-70 years · All sexes

Timeline

2012 – 2020

Study locations (30)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• Arizona Cancer Center, Phoenix, Arizona, United States
• City of Hope National Medical Center, Duarte, California, United States
• University of California at Los Angeles, Los Angeles, California, United States
• Stanford Hospital and Clinics, Stanford, California, United States
• University of Florida College of Medicine (Shands), Gainesville, Florida, United States
• Florida Hospital Cancer Institute, Orlando, Florida, United States
• Emory University, Atlanta, Georgia, United States
• BMT Program at Northside Hospital, Atlanta, Georgia, United States
• University of Kansas Hospital, Kansas City, Kansas, United States
• Johns Hopkins University, Baltimore, Maryland, United States
• DFCI Massachustts General Hospital, Boston, Massachusetts, United States
• DFCI Brigham & Women's Hospital, Boston, Massachusetts, United States
• University of Michigan Medical Center, Ann Arbor, Michigan, United States
• Karmanos Cancer Institute/BMT, Detroit, Michigan, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · National Cancer Institute (NCI) · Blood and Marrow Transplant Clinical Trials Network · National Marrow Donor Program

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University
• RECRUITINGNANCT07201974
  Virtual Reality for Post-Stroke Gait Rehabilitation
  McGill University

See all trials for Acute lymphoblastic leukemia →